Friday 6 November 2026 Export CAH’s income statement to Excel — free account

Cardinal Health, Inc.

Cardinal Health, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $254.2 billion, up 14.2% from fiscal 2025.

Revenue: +5.47%
EPS: +26.3%
Free cash flow: +10.9%
Total debt: −2.40%

Quarter to September 2026, against a year earlier

267.66 5.73 +2.19%

Follow CAH

Alert me

Market cap: $62.0B
P/E: 34.5×
Fwd P/E: 24.5×
Dividend yield: 0.77%
F-score: 7/9
Altman Z: 5.09
Beneish M: −2.74
Dividend safety: 86/100

Overview Earnings & Analysis Segments Valuation Filings

Cardinal Health, Inc. (CAH) revenue by segment, product and region

Where the money comes from and where it goes

Fiscal 2026: revenue by segment, and margins
Pharmaceutical and Specialty Solutions	234,833	92.36%
GMPD	12,719	5.00%
Other Operating Segment	6,792	2.67%
Gross margin		3.84%
Operating margin		1.03%
Pre-tax margin		0.86%

Revenue by segment $m

Line	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010
Pharmaceutical and Specialty Solutions	234,833 92.36%	204,644 91.94%	210,019 92.59%	188,814 92.11%	164,596 90.77%	—	—	—	—	—	—	—	—	—	—	—	—
GMPD	12,719 5.00%	12,636 5.68%	12,381 5.46%	12,222 5.96%	13,280 7.32%	—	—	—	—	—	—	—	—	—	—	—	—
Other Operating Segment	6,792 2.67%	5,382 2.42%	4,512 1.99%	4,021 1.96%	3,518 1.94%	—	—	—	—	—	—	—	—	—	—	—	—
Pharmaceutical Member	—	—	—	—	—	145,796 89.74%	137,495 89.91%	129,917 89.27%	121,241 88.62%	116,463 89.60%	109,131 89.79%	91,116 88.87%	80,110 87.95%	91,097 90.11%	97,925 91.05%	93,744 91.33%	89,790 91.15%
Medical Member	—	—	—	—	—	16,687 10.27%	15,444 10.10%	15,633 10.74%	15,581 11.39%	13,524 10.40%	12,430 10.23%	11,395 11.11%	10,962 12.04%	10,060 9.95%	9,642 8.96%	8,922 8.69%	8,750 8.88%
Corporate, Non-Segment	—	—	—	—	—	—	—	—	—	—	—	—	—	(64) (0.06%)	(15) (0.01%)	(22) (0.02%)	(37) (0.04%)
Operating Segments	—	—	—	—	—	—	—	—	—	—	—	—	—	101,157	107,567	102,666	98,540
Revenue	254,248	222,578	226,827	204,979	181,326	162,467	152,922	145,534	136,809	129,976	121,546	102,531	91,084	101,093	107,552	102,644	98,503

Operating income by segment $m, and margin

	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010
Pharmaceutical and Specialty Solutions	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Other Operating Segment	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
GMPD	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Pharmaceutical Member	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Medical Member	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Corporate, Non-Segment	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Corporate and other	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Operating income	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡

Revenue by region $m

Line	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012
UNITED STATES	252,639 99.37%	220,993 99.29%	225,231 99.30%	203,440 99.25%	179,471 98.98%	157,756 97.10%	148,707 97.24%	141,479 97.21%	132,539 96.88%	125,017 96.18%	116,864 96.15%	98,435 96.01%	87,449 96.01%	97,994 96.93%	105,205 97.82%
Non-US	1,705 0.67%	1,669 0.75%	1,681 0.74%	1,617 0.79%	1,923 1.06%	4,727 2.91%	4,232 2.77%	4,071 2.80%	4,283 3.13%	4,970 3.82%	4,682 3.85%	4,096 3.99%	3,635 3.99%	3,099 3.07%	2,347 2.18%
Revenue	254,248	222,578	226,827	204,979	181,326	162,467	152,922	145,534	136,809	129,976	121,546	102,531	91,084	101,093	107,552

As each company reports them in its 10-K and 10-Q filings, in US dollars. Where a later filing recast a year's segments, the year is shown as recast; a period whose breakdown does not add up to the company's revenue is left out.